Concepedia

G A Bullard

GA

Statistics

Publications

5

Citations

225

H-Index

5

Active since

1993

Affiliations

Roswell Park Comprehensive Cancer Center(Current)

G A Bullard is an author at Roswell Park Comprehensive Cancer Center specializing in pharmacokinetics of anticancer agents, liposomal formulations, and toxicology.

Publications per year

1993–2020

5

Publications

5

Comparison of the cardiotoxic effects of liposomal doxorubicin (TLC D-99) versus free doxorubicin in beagle dogs.

Peter M. Kanter, G A Bullard, RJ Ginsberg et al. · PubMed · 1993 · 64 citations

, , +17

Preclinical toxicology study of liposome encapsulated doxorubicin (TLC D-99): comparison with doxorubicin and empty liposomes in mice and dogs.

Peter M. Kanter, G A Bullard, Frank G. Pilkiewicz et al. · PubMed · 1993 · 57 citations

, , +16

Liposome encapsulated vincristine: preclinical toxicologic and pharmacologic comparison with free vincristine and empty liposomes in mice, rats and dogs

Peter M. Kanter, Gary M Klaich, G A Bullard et al. · Anti-Cancer Drugs · 1994 · 45 citations

, , +17

Biocontrol of Crown Gall by Rhizobium rhizogenes: Challenges in Biopesticide Commercialisation

A. Kerr, G A Bullard · Agronomy · 2020 · 39 citations · Full text

, , +16

Preclinical toxicology study of liposome encapsulated doxorubicin (TLC D-99) given intraperitoneally to dogs.

Peter M. Kanter, Gary M Klaich, G A Bullard et al. · PubMed · 1995 · 20 citations

, , +15

1–5 of 5